These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 8452500

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ.
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR, King DJ.
    Vaccine; 2005 May 16; 23(26):3424-33. PubMed ID: 15837366
    [Abstract] [Full Text] [Related]

  • 5. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
    Ganapathy K, Cox WJ, Gough RE, Cargill P, Montiel E, Jones RC.
    Avian Pathol; 2007 Aug 16; 36(4):313-7. PubMed ID: 17620178
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW, Gelb J, Schreurs CS, Lütticken D, Rosenberger JK, Sondermeijer PJ.
    Avian Dis; 1992 Aug 16; 36(4):858-70. PubMed ID: 1485872
    [Abstract] [Full Text] [Related]

  • 8. Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus.
    Bolte AL, Voss M, Vielitz E, Kaleta EF.
    Dtsch Tierarztl Wochenschr; 2001 Apr 16; 108(4):155-9. PubMed ID: 11370475
    [Abstract] [Full Text] [Related]

  • 9. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V, Kiss I, Tatár-Kis T, Mató T, Felföldi B, Gardin Y.
    Avian Dis; 2012 Jun 16; 56(2):282-7. PubMed ID: 22856183
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ, King DJ, Afonso CL, Suarez DL.
    Vaccine; 2007 Oct 10; 25(41):7238-46. PubMed ID: 17719150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
    Swayne DE, Suarez DL, Schultz-Cherry S, Tumpey TM, King DJ, Nakaya T, Palese P, Garcia-Sastre A.
    Avian Dis; 2003 Oct 10; 47(3 Suppl):1047-50. PubMed ID: 14575108
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.